Recent Company News

• 09:19 AM ET Jun 06, 2025
  

  Apellis Pharmaceuticals presents new data from open-label period of Phase 3 VALIANT study investigating EMPAVELI (pegcetacoplan) for C3G and IC-MPGN ($19.10, 0.00)

• 09:17 AM ET Jun 06, 2025
  

  Swedish Orphan Biovitrum and Apellis Pharmaceuticals present new data from open-label period of Phase 3 VALIANT study

• 01:10 AM ET Jun 06, 2025
  

  Asahi Kasei reports May value of monthly home orders (28%) y/y (¥980.5000, -7.5)

• 05:47 PM ET Jun 03, 2025
  

  Asahi Kasei downgraded to hold from outperform at CLSA (¥1016.0000, 0)

• 08:01 PM ET May 29, 2025
  

  Japan April retail sales +3.3% y/y, seasonally-adjusted retail sales +0.5% m/m

• 02:46 AM ET May 27, 2025
  

  Asahi Kasei to discontinue MMA, CHMA, PMMA resin, SB latex businesses; to reconfigure acetonitrile supply framework (¥1004.0000, 0)

• 02:23 AM ET May 19, 2025
  

  Japan March electronics exports ¥1.163T, +0.9% y/y

• 03:04 AM ET May 13, 2025
  

  Honda Motor to postpone by ~2 years its plan to establish comprehensive EV value chain in Ontario, Canada (¥1503.5000, 0)

• 01:19 AM ET May 13, 2025
  

  Asahi Kasei reports April value of monthly home orders (14%) y/y (¥1019.5000, +2.5)

• 11:46 PM ET May 08, 2025
  

  Asahi Kasei reports FY net income attributable ¥135.00B vs guidance ¥110.00B and FactSet ¥115.56B [10 est, ¥110-125.30B] (¥994.8000, -2.6)